Pro-Dex (PDEX) vs SS Innovations International (SSII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pro-Dex (PDEX) has outperformed SS Innovations International (SSII) over the past year, gaining 92.9% versus a loss of 78.7%. SS Innovations International is the larger company by market cap ($254.9 million vs $201.6 million), about 1.3 times the size. Pro-Dex converts more of its revenue into profit, with a net margin of 17.6% versus -28.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDEX | SSII |
|---|---|---|
| Share price | $63.00 | $1.27 |
| Market cap | $201.60M | $254.86M |
| 1-day change | -0.77% | -0.78% |
| YTD return | +63.72% | -77.64% |
| 1-year return | +92.90% | -78.69% |
| 5-year return | +180.25% | — |
| P/E ratio (TTM) | 17.36 | — |
| Forward P/E | 18.16 | — |
| EPS (TTM) | $3.63 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $77.55M | $42.48M |
| Revenue growth (YoY) | +16.45% | +105.74% |
| Net income (latest FY) | $13.66M | $-12.13M |
| Gross margin | 31.38% | 46.00% |
| Operating margin | 16.75% | -19.29% |
| Net margin | 17.62% | -28.55% |
| 52-week high | $77.00 | $6.79 |
| 52-week low | $32.14 | $1.12 |
| Distance from 52-week high | -18.18% | -81.30% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +26.98% | +451.18% |
| Average volume | 54.15K | 86.18K |
| Shares outstanding | 3.20M | 200.68M |
| Employees | 201 | 483 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed SSII by 171.6 percentage points over the past year.
- Pro-Dex is more profitable, keeping 17.6 cents of every revenue dollar as net income versus -28.5 cents for SS Innovations International.
- SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs +16.45%).
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
PDEX vs SSII FAQ
Which is bigger, Pro-Dex or SS Innovations International?
SS Innovations International (SSII) is larger, with a market capitalization of $254.86M compared with $201.60M for Pro-Dex (PDEX).
Which stock has performed better over the past year, PDEX or SSII?
PDEX returned +92.90% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.
Are Pro-Dex and SS Innovations International in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.